241 related articles for article (PubMed ID: 26899595)
1. A potent and selective inhibitor targeting human and murine 12/15-LOX.
Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
[TBL] [Abstract][Full Text] [Related]
2. Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
Rai G; Joshi N; Jung JE; Liu Y; Schultz L; Yasgar A; Perry S; Diaz G; Zhang Q; Kenyon V; Jadhav A; Simeonov A; Lo EH; van Leyen K; Maloney DJ; Holman TR
J Med Chem; 2014 May; 57(10):4035-48. PubMed ID: 24684213
[TBL] [Abstract][Full Text] [Related]
3. Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.
Tsai WC; Gilbert NC; Ohler A; Armstrong M; Perry S; Kalyanaraman C; Yasgar A; Rai G; Simeonov A; Jadhav A; Standley M; Lee HW; Crews P; Iavarone AT; Jacobson MP; Neau DB; Offenbacher AR; Newcomer M; Holman TR
Bioorg Med Chem; 2021 Sep; 46():116349. PubMed ID: 34500187
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of the Maresin Intermediate, 13S,14S-Epoxy-DHA, by Human 15-Lipoxygenase and 12-Lipoxygenase and Its Regulation through Negative Allosteric Modulators.
Freedman C; Tran A; Tourdot BE; Kalyanaraman C; Perry S; Holinstat M; Jacobson MP; Holman TR
Biochemistry; 2020 May; 59(19):1832-1844. PubMed ID: 32324389
[TBL] [Abstract][Full Text] [Related]
5. Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.
Armstrong M; van Hoorebeke C; Horn T; Deschamps J; Freedman JC; Kalyanaraman C; Jacobson MP; Holman T
Bioorg Med Chem; 2016 Nov; 24(21):5380-5387. PubMed ID: 27647374
[TBL] [Abstract][Full Text] [Related]
6.
Tsai WC; Kalyanaraman C; Yamaguchi A; Holinstat M; Jacobson MP; Holman TR
Biochemistry; 2021 Jun; 60(22):1741-1754. PubMed ID: 34029049
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.
Armstrong MM; Diaz G; Kenyon V; Holman TR
Bioorg Med Chem; 2014 Aug; 22(15):4293-7. PubMed ID: 24924423
[TBL] [Abstract][Full Text] [Related]
8. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
[TBL] [Abstract][Full Text] [Related]
9. A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.
Jameson JB; Kantz A; Schultz L; Kalyanaraman C; Jacobson MP; Maloney DJ; Jadhav A; Simeonov A; Holman TR
PLoS One; 2014; 9(8):e104094. PubMed ID: 25111178
[TBL] [Abstract][Full Text] [Related]
10. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
11. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
[TBL] [Abstract][Full Text] [Related]
12. 12/15 Lipoxygenase as a Therapeutic Target in Brain Disorders.
Karatas H; Cakir-Aktas C
Noro Psikiyatr Ars; 2019 Dec; 56(4):288-291. PubMed ID: 31903039
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Investigations of Acyl-CoA Derivatives against Human Lipoxygenase Isozymes.
Tran M; Yang K; Glukhova A; Holinstat M; Holman T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446119
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.
Hernandez-Perez M; Chopra G; Fine J; Conteh AM; Anderson RM; Linnemann AK; Benjamin C; Nelson JB; Benninger KS; Nadler JL; Maloney DJ; Tersey SA; Mirmira RG
Diabetes; 2017 Nov; 66(11):2875-2887. PubMed ID: 28842399
[TBL] [Abstract][Full Text] [Related]
15. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
[TBL] [Abstract][Full Text] [Related]
16. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
[TBL] [Abstract][Full Text] [Related]
17. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia.
Jin G; Arai K; Murata Y; Wang S; Stins MF; Lo EH; van Leyen K
Stroke; 2008 Sep; 39(9):2538-43. PubMed ID: 18635843
[TBL] [Abstract][Full Text] [Related]
18. O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors.
Jabbari A; Mousavian M; Seyedi SM; Bakavoli M; Sadeghian H
PLoS One; 2017; 12(2):e0171789. PubMed ID: 28182779
[TBL] [Abstract][Full Text] [Related]
19. 5 S,15 S-Dihydroperoxyeicosatetraenoic Acid (5,15-diHpETE) as a Lipoxin Intermediate: Reactivity and Kinetics with Human Leukocyte 5-Lipoxygenase, Platelet 12-Lipoxygenase, and Reticulocyte 15-Lipoxygenase-1.
Green AR; Freedman C; Tena J; Tourdot BE; Liu B; Holinstat M; Holman TR
Biochemistry; 2018 Dec; 57(48):6726-6734. PubMed ID: 30407793
[TBL] [Abstract][Full Text] [Related]
20. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]